NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/30/2024
Back to search
Official data from USPTO
IMMUNOCORE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNOCORE
ST13
US500000087264976Class
5, 42
Filing
87264976
Registration
5410175
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
11/30/2024
Trademark type
Word
Nice classes
5, 42
Filing date
12/12/2016
Registration date
02/27/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2024
Last transaction
11/30/2024
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Abingdon, Oxfordshire, GB
Examiner
NUNLEY, CHRISTOPHER
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Immunocore Limited
Representatives
Andrew D. Price & Paula E. Hopkins VENABLE LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancerinfectious diseases and autoimmune diseases; biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancerinfectious diseases and autoimmune diseases; immunotherapeutic drugs; reagents for medical use; Biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; diagnostic preparations for medical purposes; diagnostic reagents for medical use
Class 42
Pharmaceutical testing and clinical trials for others; provision of information and consultancy in relation to the aforesaid services; scientific and technological servicesresearch and design in the field of drug development for the treatment of cancerinfectious diseases and autoimmune diseases; pharmaceutical research and development services; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services
Publications
History of USPTO decisions and trademark events.
28 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/30/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/30/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/20/2024
E815
TEAS SECTION 8 & 15 RECEIVED
06/20/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/27/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/27/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2017
PUBO
PUBLISHED FOR OPPOSITION
12/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2017
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
11/08/2017
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/31/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
10/25/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/25/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
10/25/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/25/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2017
ALIE
ASSIGNED TO LIE
09/26/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2017
GNRT
NON-FINAL ACTION E-MAILED
03/22/2017
CNRT
NON-FINAL ACTION WRITTEN
03/22/2017
DOCK
ASSIGNED TO EXAMINER
03/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2016
NWAP
NEW APPLICATION ENTERED
12/15/2016
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOCORE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.